Exosome Diagnostics logo

Exosome Diagnostics

ID: 5290481

A company developing and commercializing cancer molecular diagnostics based isolation of exosomes from body fluids. Exosome Diagnostics was founded in 2008.

3

Funding Rounds

$53.5m

Money raised

Overview

A company developing and commercializing cancer molecular diagnostics based isolation of exosomes from body fluids. Exosome Diagnostics was founded in 2008.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Exosome Diagnostics has raised a total of $26.5m in funding over 3 rounds.

Key Insights:

  • Exosome Diagnostics Series B round: $6.5m
  • Exosome Diagnostics Series A round: $20m
  • Exosome Diagnostics Series B round March 2014: $27m

Industries

Exosome Diagnostics is active in the following industries: